Loading
A phase 3 trial of trifluridine/tipiracil and capecitabine in colorectal cancer, run by Shandong Cancer Hospital and Institute, now recruiting.
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial is a phase 3, randomised interventional study registered as NCT06850090 by Shandong Cancer Hospital and Institute, with a registry enrolment figure of 210 participants, started 2025-07-30 and due to reach its primary completion in 2027-06. Interventions recorded: TAS-102; Capecitabine. Conditions listed: Rectal Cancer; Rectal Cancer Patients. Primary outcome: Complete response (CR) rate. Colorectal eligibility wording from the registry: "Histologically confirmed rectal adenocarcinoma with the following conditions:". Sites: China. No results are recorded here; the registry entry is the source.
Shares Trifluridine/tipiracil, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Cytotoxic chemotherapy and the tag colorectal-deep-dive.